Changing the Timing of Enzalutamide Intake from Morning to before Sleep at Night Overcame Enzalutamide-Induced Dysgeusia
Dysgeusia is an adverse effect caused by enzalutamide said to affect 1–5% of patients. The reported management strategies include a temporary drug holiday, the prescription of herbal medicine, and changing the timing of enzalutamide intake from morning to before sleep at night. Case 1: A 72-year-old...
Main Authors: | Takashi Kawahara, Yasuhide Miyoshi, Masahiro Yao, Hiroji Uemura |
---|---|
Format: | Article |
Language: | English |
Published: |
Karger Publishers
2019-08-01
|
Series: | Case Reports in Oncology |
Subjects: | |
Online Access: | https://www.karger.com/Article/FullText/502054 |
Similar Items
-
The Achievement of Long-Term CRPC Control in a Patient with Enzalutamide-Induced Nausea and Fatigue after Overcoming the Adverse Events with a Temporary Drug Holiday
by: Takashi Kawahara, et al.
Published: (2019-07-01) -
Management of Dysgeusia related to Cancer
by: DURGESHWORI MUNANKARMI
Published: (2017-05-01) -
A high neutrophil-to-lymphocyte ratio is a poor prognostic factor for castration-resistant prostate cancer patients who undergo abiraterone acetate or enzalutamide treatment
by: Takashi Kawahara, et al.
Published: (2020-09-01) -
Phantosmia, Parosmia, and Dysgeusia Are Prolonged and Late-Onset Symptoms of COVID-19
by: Sophia E. Schambeck, et al.
Published: (2021-11-01) -
Dysgeusia in Patients with Breast Cancer Treated with Chemotherapy—A Narrative Review
by: Marianna Pellegrini, et al.
Published: (2023-01-01)